Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
NFYS.WS was delisted on the 24th of July, 2024.
31 hedge funds and large institutions have $15.7M invested in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
15% more funds holding
Funds holding: 27 → 31 (+4)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
4% less capital invested
Capital invested by funds: $16.4M → $15.7M (-$671K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
CAAS Capital Management
New York
|
+$237K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$103K |
| 3 |
Parallax Volatility Advisers
San Francisco,
California
|
+$81.9K |
| 4 |
OCAM
Owl Creek Asset Management
New York
|
+$70.7K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$57.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$82K |
| 2 |
DCP
Diameter Capital Partners
New York
|
-$63.4K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$16K |
| 4 |
FLC
Fifth Lane Capital
Austin,
Texas
|
-$4K |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$901 |
NFYS.WS Hedge Fund Activity: Q2 2022 in Review
31 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) for Q2 2022, worth a combined $15.7M — down 4.1% from $16.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NFYS.WS positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was CAAS Capital Management, opening a new position worth an estimated $237K. The largest seller was Citadel Advisors, exiting entirely with an estimated $82K sold.
- 31 institutional investors held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) as of Q2 2022, up from 27 in Q1 2022.
- Funds reported $15.7M of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 stock for Q2 2022, down 4.1% quarter-over-quarter.
- 7 funds opened new Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 positions in Q2 2022 and 3 closed out, a net change of +4 holders.
- The largest Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 buyer in Q2 2022 was CAAS Capital Management, an estimated $237K added.
- The largest Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 seller in Q2 2022 was Citadel Advisors, an estimated $82K sold.
Based on aggregated 13F filings for Q2 2022.